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ABSTRACT OF THE THESIS
Investigation of 89Zr-Siderophores as Molecular Imaging Agents for Positron Emission Tomography
Imaging of Bacterial Infections
by
Nora Catharina Mary Goscinski
Master of Arts in Chemistry
Washington University in St. Louis, 2015
Professor Suzanne E. Lapi, Chair

Siderophores are small molecules synthesized by bacteria to harvest Fe3+ from their
environment. In infection scenarios, their production can increase infection virulence by increasing the
ability of bacteria to obtain Fe3+ and therefore grow more rapidly. The selective uptake of siderophores
in vivo in multi-bacteria environments indicates that this class of molecules has a potential use as
selective imaging agents. In this work, DFO-NCS and a library of trihydroxamate siderophores were
evaluated as vehicles to deliver 89Zr selectively to bacteria for Positron Emission Tomography (PET)
imaging of bacterial infections.

Productive work with radiometals involves thorough knowledge of the element’s chemistry as
well as the sources and detrimental effects of any contaminating metal ions present with the radiometal
in the reaction mixture. As a case study to determine the factors likely to interfere with the
complexation of any given radiometal, the quality control assay used to determine effective specific
activity (ESA) of 64Cu was intensely examined. The purpose of this study was to identify sources of
viii

cold metal contaminants in the 64Cu production process and to identify which of those metals interfere
with the binding of 64Cu to the TETA chelator. The TETA titration method for determining 64Cu ESA
has relative standard deviations of 27.6% and 40.3% for repeatability and reproducibility respectively
and the chelator TETA is selective for picomolar amounts of Cu2+ in the presence of low millimolar
concentrations of Zn2+ and Ni2+.

When the 89Zr-DFO-NCS complex was tested against a panel of cell types, the uptake by human
cells (SKBR3), Staphylococcus aureus cells, and Pseudomonas aeruginosa cells was significantly
different (p<0.0001) and highest for S. aureus. The Zr chemistry and bacterial uptake behavior of a
library of trihydroxamate siderophores was then evaluated and compared to that of DFO-NCS. The
uptake of 89Zr-DFO-NCS and a siderophore library member (89Zr-V-129) were tested in a murine lung
infection model (P. aeruginosa, PA M57-15) and the lung uptake of 89Zr-V-129 was found to be
significantly higher in infected mice (p=0.012035) than in control mice. The uptake of 89Zr-DFO-NCS
did not differ significantly between control and infected mice (p=0.831).

89

Zr-siderophores have been

shown to possess potential to be selective, specific PET tracers for imaging bacterial infections in vivo
and their utility for infection imaging should be more thoroughly explored.

ix

Chapter 1: Introduction to Radiochemistry
While all chemists are familiar with the periodic table, which organizes the known elements by
proton number and similarity of chemical behavior, nuclear and radiochemists have an additional
reference available to them, the chart of the nuclides (figure 1-1, below). The chart of the
nuclides can be thought of as an extended periodic table, where each box represents a single
nucleus rather than the average elemental mass presented in each box of the periodic table.
Proton number is plotted in the y-direction, neutron number in the x-direction, and a third
quantity (mass) can be imagined to be plotted along the z-axis. The nucleus with lowest mass
along an isobar (white arrow) is the most stable. The valley of stability (black boxes) runs
approximately through the center of the nuclides, but bends ‘south’ as neutron number increases.

Figure 1: The Chart of the Nuclidesa

a

https://www-nds.iaea.org/relnsd/vcharthtml/VChartHTML.html
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1.1 Types of Radioactive Decay
Unstable nuclei undergo radioactive decay when the daughter nucleus has a higher binding
energy per nucleon than the parent nucleus [2]. Stated another way, a nucleus will undergo a
particular mode of radioactive decay if the sum of the masses of particles after the decay is less
than the initial mass of the unstable nucleus [2, 3]. However, nuclei may achieve this goal by a
variety of routes. The three main modes of radioactive decay are alpha, beta (β- ,β+, or electron
capture) and gamma emission. Although fission is a route by which certain unstable nuclei may
reach stability, it will not be discussed in this work.

1.1.1 Alpha Decay
When a nucleus undergoes alpha decay, the parent nucleus ejects a helium nucleus (2 protons, 2
neutrons), also known as an alpha particle [2].
210
84𝑃𝑜

→ 42𝐻𝑒 +

206
82𝑃𝑏

(1)

The ejected α particle travels until it acquires 2 electrons and becomes an uncharged He atom.
With a few key exceptions (such as 8Be), nuclei that decay via alpha particle emission tend to be
rather massive (A≥208 [3]) and are found at the upper end of the chart of the nuclides (high-Z,
high-A nuclei) (figure 1-1).

1.1.2 Beta Decay
Most nuclei decay via one of the three modes of beta particle emission [2, 4]. Typically, nuclei
below the valley of stability decay via β- emission[2, 3]. In this decay mode, a neutron in the
nucleus decays to a proton, an electron and an anti-neutrino:
90
39𝑌

→

90
40𝑍𝑟

+ 𝛽− + 𝜈

(2)

The daughter nucleus ejects the electron and anti-neutrino and these ejecta travel until the
electron is moving slowly enough to be incorporated into an atomic electron cloud. The antineutrino interacts minimally with matter and travels great distances.
2

Nuclei above the valley of stability decay are proton-rich and therefore decay via β+ emission or
electron capture. In β+ emitting nuclei, a proton decays to a neutron, as well as a positron (β+, the
anti-matter of the electron) and a neutrino [2, 3]:

89
40𝑍𝑟

→

89
39𝑌

+ 𝛽+ + 𝜈

(3)

As in β- decay, the daughter nucleus ejects the leptons, in this case the positron and neutrino.
However, once the β+ has lost sufficient energy to be captured, it is captured by an ordinary
electron [3]. The captured β+ may form a neutral complex (known as Positronium, Ps) with the
capturing electron, or may immediately undergo annihilation [2]. The Ps complex is very shortlived and the β+ and e- soon annihilate one another, producing two γ photons (511 keV each) at
~180⁰ relative to each otherb [2, 3]. These two coincident photons are the basis of the nuclear
imaging technique Positron Emission Tomography (PET, see section 1.3.3) [2, 3, 5].

A third mode of β decay, known as electron capture, occurs when the nucleus captures a lowenergy atomic electron, transforming a proton into a neutron [2, 3]. Nuclei undergoing electron
capture decay lie above the line of stability, but lack sufficiently large Q values (mass difference
between nuclei on an isobar) to undergo positron decay [2].

The angle between annihilation photons is not always precisely 180 degrees but this work
makes the assumption that any variation in this angle is too small to drastically alter any results
obtained from the study of positron-emitting nuclides in vivo.
3
b

1.1.3 Gamma Decay
Immediately after a nucleus decays by α or β emission, the daughter nucleus typically exists in a
highly excited state [2, 3]. This excited daughter then relaxes to a lower-energy ground state via a
variety of modes. Electromagnetic radiation is released from the daughter nucleus as a result of
this relaxation. Such radiation originating from the nucleus is known as gamma (γ) radiation [2].
While γ emission does not result in a new element, it does result in a more stable nucleus. Often,
the γ is emitted extremely close in time to the β decay event, but a few nuclides exist in which
the emission of γ radiation by the excited daughter nucleus is delayed by minutes to hours [2].
These long-lived excited daughters are known as metastable isomers of a nuclide [2] and can be
isolated from the parent material for use in applications requiring photons, such as medical
imaging. A metastable isomer commonly used in medicine is 99mTc[4, 5], used in single photon
emission computed tomography (SPECT)[4], which is produced according to the following
(simplified) scheme:

99
42𝑀𝑜

→ 𝛽 − + 99𝑚
43𝑇𝑐 →

99
43𝑇𝑐

+ 𝛾 (140 𝑘𝑒𝑉)

(4)c

The 140 keV γ photons given off by the relaxation of 99mTc to 99Tc can be used to image disease
within the body if attached to a suitable pharmaceutical [4, 5].

1.2 Production of Radioisotopes
There are two main routes by which radioisotopes are produced for research and clinical
applications. Nuclei formed by neutron bombardment of the parent nucleus may be produced in

c 99

Mo is typically produced by the fission of 235U in nuclear reactors.
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nuclear reactors, while nuclides formed by proton bombardment of parent material may be
produced using particle accelerators [2].

1.2.1 Nuclear Reactors
Nuclear reactors consist of rods of fissile uranium fuel (235U) immersed in a neutron-slowing
medium such as water or graphite (see figure 1-2 for a schematic of a research reactor, below).

Figure 1-2: A typical “swimming pool” research reactor (a TRIGA IPR-R1) [6]

The fuel is arranged in a manner allowing a self-sustaining chain fission reaction to occur in a
controllable manner [2, 3, 5]. Samples of the target material are typically sealed in quartz vials [2]
and immersed in the reactor where they are bombarded by the sea of thermalized (slow) neutrons
[2]

. The capture cross section of the target nucleus is maximized at low average energies of

incident neutrons, so ‘slow’ neutrons are most likely to induce nuclear reactions and transmute
the parent into a daughter nucleus.
Because both parent and daughter have the same number of protons, the daughter is chemically
identical to the parent material. This can make isolation of the pure daughter nucleus difficult, as
5

the parent and daughter can only be separated by physical methods, rather than by chemical
means. Therefore, neutron irradiation in a nuclear reactor typically produces daughter nuclides
with low specific activity (amount of radioactivity per unit mass) since large amounts of parent
material remain with the daughter nuclide.
However, there are some cases (such as the production of 111Ag from 110Pd [7, 8]) in which the
daughter formed by neutron bombardment is short-lived and decays via to a longer-lived,
chemically distinct grand-daughter nuclide, allowing isolation of the 111Ag with high specific
activity. Radionuclides produced via neutron irradiation in nuclear reactors tend to lie below the
valley of stability.

1.2.2 Accelerators
Isotopes produced via bombardment of a parent nucleus with charged particles may be produced
in particle accelerators [2, 3]. While linear accelerators may be used to irradiate target materials
[2]

, in practice most radioisotopes for biomedical imaging studies are produced in cyclotrons,

which are more space-efficient [5]. A typical cyclotron is shown in figure 1-3, below.

Figure 1-3: Cyclotron for production of radionuclides d

d

http://www.daviddarling.info/encyclopedia/C/cyclotron.html
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An ion source produces charged particles for acceleration; while these may be either cations or
anions, a given machine will only use one. Under the influence of an electric field, the ions
(typically H-) move from the ion source to the electromagnets of the machine, where their path is
curved by a magnetic field. When the ions reach the gap between the “dees” (charged plates
between magnets), the electric field is reversed, accelerating the ions across the gap between
dees [2, 5]. After this acceleration, the H- have a higher energy and traverse a path longer than
their original route within the dee, until they reach the gap between dees again. This process
continues until the ions have achieved some maximum energy (dependent on the strength of the
magnetic field and radius of the electrodes)[2, 4, 5]. When the H- cannot be accelerated any
further, they are routed through a stripper foil (to remove electrons and convert H- to H+), after
which they curve out of the dee structure. The H+ then bombard the target, reacting with nuclei
and transmuting target nuclei into chemically distinct product nuclei[2]. Typically, this initial
product nucleus is an extremely short-lived compound nucleus that evaporates at least one
nucleon in order to achieve a more stable configuration of protons and neutrons[4]. It is this final
product nucleus that is isolated from the target after irradiation. Radionuclides of medical
interest produced by this method include 18F, 64Cu, 89Zr, and 11C (Table 1-1)
Table 1-1: Commonly used medical radionuclides and their production methods

Radionuclide

Production Reaction

F

18
18
[9]
8𝑂 (𝑝, 𝑛) 9𝐹

C

14
11 [10]
7𝑁(𝑝, 𝛼) 6𝐶

Cu

64
64
[11, 12]
28𝑁𝑖(𝑝. 𝑛) 29𝐶𝑢

18

11

64

89

89
89
[13]
39𝑌(𝑝, 𝑛) 40𝑍𝑟

Zr

7

Radionuclides produced by charged particle irradiation typically lie above the valley of stability.
They may decay by β+ or EC emission, depending on the parent nucleus irradiated.

1.2.3 Comparison of Methods
Target irradiations in accelerators and in reactors are complementary methods of radionuclide
production. As positron emission only occurs in nuclei above the line of stability, isotopes used
in PET are produced on charged-particle accelerators[5]. However, nuclei below the line of
stability are usually produced in nuclear reactors and these nuclides are often crucial for imaging
and radiotherapy. The most commonly used isotope in nuclear medicine (99mTc) is produced
from a reactor-derived parent (99Mo).

1.3 Molecular Imaging
Molecular imaging can be defined as the study and application of molecules and machinery that
permit non-invasive examination of biological processes in living organisms, rather than mere
structural information[14]. While the most obvious application of molecular imaging is in the
diagnosis and monitoring of disease, it can also be used to examine healthy biological systems.
At its heart, molecular imaging is the quest to “see” specific chemical and biological processes
and act on the information gleaned from said observation.

1.3.1 Glossary
To simplify the discussion, the following definitions will be used throughout this work:
Tracer: An entity, usually a molecule, that can be introduced to a living system and whose
movement within that living system can be observed non-invasively.
Beacon: The part of the tracer responsible for the signal observed from outside the subject. For
example, it may be a colored or fluorescent dye, a magnetically active metal ion or a radioactive
atom.

8

Targeting moiety: The part of the tracer that binds to a specific biological structure or causes the
tracer as a whole to behave in a particular manner.

1.3.2 The Tracer Principle
While not true for all imaging modalities, many molecular imaging techniques rest on a
statement known as “the tracer principle”. In its simplest form, this principle states that
molecules used to probe biological systems do not perturb the system under observation
provided the tracer concentration is sufficiently low. Furthermore, it assumes that molecules
altered to be detectable through non-invasive methods (tracers) behave in a biologically identical
manner to the unaltered molecules [2, 5]. This assumption is not strictly true, but in some imaging
modalities, the difference between labeled and unlabeled tracer behavior is so small it can
effectively be ignored[5].

1.3.3 Positron Emission Tomography
One of these methods is Positron Emission Tomography (PET). PET relies on detection of the
coincident 511 keV γ photons produced by the annihilation of a β+ with an ordinary electron[2].
Tracers used for this imaging modality must therefore contain atoms which decay via β+
emission. The operating principle of a typical PET scanner is shown below, in figure 1-4. When
two detectors in the ring detect an event simultaneously, the event is tagged as a coincidence
event, and the tracer is assumed to lie along the line between the two detectors [2] (known as the
line of response, LOR). Detection of many LOR’s allows the exact location of the tracer within
the system (typically a human patient) to be determined [5].

9

Figure 1-4: Positron Emission Tomography apparatuse

PET is a very sensitive technique [15]. The concentration of contrast agent in the body is usually
10−12 mols/L or lower after injection [16, 17], so it does not measurably perturb the biological
functions observed via PET. Additionally, the beacon attached to the targeting moiety is
extremely small (a single atom), so it is unlikely to alter the tracer’s pharmacokinetic behavior in
vivo. Because radioactivity is the signal monitored in PET, nearly background-free
measurements are possible as essentially no positron-emitting nuclides are naturally present in
the bodyf . Background-free images are easier to interpret, since any signal present is from the
administered tracer, rather than from an endogenous entity. Finally, PET is a functional imaging
modality, rather than an anatomical one. Instead of showing what tissues and structures are
present, PET scans present information about the chemical and biological state of the system
imaged [5]. Thus, chemical pathways specific to the target can be probed and information about
processes occurring in the system can be obtained.

e

Source http://www.tnw.tudelft.nl/en/about-faculty/departments/radiation-science-technology/research/particletherapy/turning-the-physical-advantages-of-protons-into-true-clinical-benefits-with-in-beam-tof-pet/
f

The exception is 40K, which has a β+ fraction of 1.0𝑥10−3 % and a half-life of 1.25𝑥109 years [17].
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1.3.4 Representative PET Isotopes
The PET isotopes in most common clinical use are 18F and 11C [4]. These nuclides are commonly
incorporated into the structure of small organic molecules such as glucose (making [18F]FDG).
These tracers have short biological half-lives (due to their small size), and many have highabundance targets in vivo, making the relatively short-lived 18F and 11C ideal candidates for
radiolabeling. Both 11C [19] and 18F [20] emit low energy β+ particles with no γ emissions other
than the annihilation photons, giving rise to clear PET images with minimal radiation dose to the
patient.
However, many imaging targets, e.g., cancer-specific receptors, are found in far lower abundance
in the body than glucose transport proteins and require tracers with longer blood circulation
times, such as monoclonal antibodies. Tracers with long biological t1/2 require radiolabeling with
longer-lived nuclides, so useful information may be extracted from imaging with these
compounds [13]. Many of the longer-lived PET isotopes are radiometals. Emerging radiometals
include 64Cu[11, 12, 21-32] and 89Zr [13, 32-43], both of which have been used to label antibodies (and
other tracer types) and image disease within the human body.

1.3.5 Medical Uses of PET Tracers
The most common clinical use of PET is to examine global glucose uptake in patients[46].
Elevated glucose uptake is known to occur in diseased sites within a patient. Hypermetabolic
cells (which take up more glucose than their neighbors) may be inflamed, infected or cancerous
(the Warburg effect) [47-49]. A PET scan with [18F]FDG will detect many of these pathologies[46].
However, [18F]FDG cannot distinguish among the various conditions that underlie the increased
glucose utilization of pathological cells[50]. There is a need to develop higher-specificity tracers
that are taken up by narrow ranges of diseased cell types.

11

A novel use of PET that has been gaining attention in recent years is for imaging bacterial
infections. The dynamics of bacterial infections and possible imaging targets specific to this
disease type will be discussed in further chapters of this work.

1.4
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Chapter 2: Bacterial Infections
2.1 Why Image Bacterial Infections?
The current diagnostic paradigm for patients appearing to have bacterial infections is timeconsuming, requiring samples from the patient to be cultured for hours to weeks before enough
bacteria are isolated to run destructive diagnostic tests [1]. The disease-causing bacteria are then
usually identified through a combination of their growth requirements, dye uptake and enzymatic
assays (such as whether the culture produces catalase)[1] (figure 2-1). Because proper
identification of the disease often takes a long time and bacterial infections tend to progress
rapidly (e.g., Yersinia pestis infections are fatal in 3-5 days if left untreated [1]), more-rapid
diagnostic techniques would allow physicians to identify what types of antimicrobial therapy
would help a patient in a clinically-relevant timeframe.

Figure 2-1: Typical identification of an unknown bacterium from clinical sample (adapted from [51])
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The ability to image bacterial disease and identify the pathogen from imaging results would
permit rapid, specific diagnosis of infection (as opposed to some other disorder causing illness)
with a particular infectious agent. Identifying the bacterium causing a patient’s disease would
allow clinicians to administer narrow-spectrum antibiotics targeted at the pathogen, eliminating
disease without also killing off “innocent bystanders” or potentially contributing to the rise of
drug-resistant bacterial strains [1, 2]. Additionally, the ability to specifically image infections
would allow long-term monitoring of infection progress and patient response to therapy,
allowing clinicians to determine whether a treatment is truly curing a patient’s disease or merely
alleviating its symptoms.

2.2 The Role of Iron in Infection Dynamics
In humans, the Fe3+ ion is used as a co-factor in a variety of proteins and enzymes [3-5]. The
common biological use of iron is as an oxygen carrier in hemoglobin and myoglobin. However,
Fe is also used as a redox center by cytochrome proteins in the electron transport chain, which is
responsible for most of a cell’s ATP production, as well as in the enzyme holo-aconitase in the
TCA cycle [5, 6]. Fe is also involved in cellular signaling, via the NO signal transduction
pathway[3].

Bacteria likewise also require iron to carry out basic life processes, such as ATP synthesis. The
bacterial electron transport chain uses cytochrome proteins with iron redox centers [7] and certain
anaerobic bacteria can use Fe3+ as a terminal electron acceptor [7]. Additionally, iron is used as a
redox cofactor for processes such as nucleotide synthesis [7, 8].
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Iron availability is a crucial determinant of bacterial virulence [4, 7, 9]. Bacterial cells need to
obtain iron from their environment in order to grow and divide within the host, to form biofilms
and to lyse host cells, among other activities associated with virulence [1, 7, 10].

Because iron is so crucial to proper cellular function in both humans and bacterial cells, the
human body has many systems to control the movement and use of iron [4, 9, 11]. Bacteria have
evolved iron-harvesting systems that attempt to evade or outwit the host’s attempt to withhold
iron from invading cells [4, 7, 10-12]. Consequently, the ability of a bacterium to obtain iron from
its environment is crucial to the successful establishment of infection.

2.3 Host Response to Infection
The human host’s response to invasion by bacteria has two components. The innate immune
system controls the pathways that are constitutively “on”, while other portions are only activated
in response to inflammation or infection-specific stimuli (such as the expression of particular
cytokines, or pathogen-synthesized molecules) [1, 9]. A key strategy of both components of the
immune response is to withhold iron from the infectious agent [4].

2.3.1 Constitutive Iron Sequestration
Iron in use in vivo is enclosed within many layers of biochemical structures [4, 6, 13]. For example,
the Fe3+ used to carry O2 in the blood is not merely complexed by heme. Heme groups nestle
inside hemoglobin, and many units of hemoglobin are contained within each erythrocyte (red
blood cell) [6, 13]. Therefore, many systems must fail before the Fe3+ ion is found in the blood.
When erythrocytes die or are lysed, additional proteins are recruited to sequester the iron [4, 6, 1013]

. Free hemoglobin is complexed by haptoglobin and the resulting complex is shuttled to the

spleen for recycling [10, 14]. Likewise, if heme is found outside hemoglobin, a protein called
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hemopexin complexes the Fe-porphyrin ring and shuttles it to the reticuloendothelial system for
recycling [10-11].

If Fe3+ manages to escape from heme, proteins circulating in the blood can bind the ion, reducing
the concentration of free Fe3+ in the blood. Some of these proteins are specifically designed to
chelate and transport Fe3+, such as transferrin (Tf) [4, 6, 12, 13], while others such as albumin are
general “workhorse” transport proteins capable of binding many entities [4, 6]. If the plasma
proteins are unavailable for binding Fe3+, the free metal can be complexed by small molecules in
the blood plasma such as citrate and free amino acids [4, 14].

An additional word should be said regarding the role of transferrin. Transferrin is a small (80
kDa) glycoprotein ordinarily found in the blood and cerebrospinal fluid whose role is to chelate
and transport Fe3+ to tissues where it is needed [3, 15]. It is internalized by endocytosis and
releases Fe3+ in the low-pH endosome before being excreted for another round of Fe3+ transport
[3]

. Because the pH of the blood, CSF and interstitial fluid is approximately neutral (pH 7.4) [16],

Fe3+ is unlikely to be released in an uncontrolled manner in healthy hosts. These fluids are
normally sterile. However, fluids which can contact the air (such as tears, saliva, bile and breast
milk) utilize a different iron transport protein. These fluids tend to have a lower pH than blood
[1]

and also may encounter bacteria. An iron transport protein that releases Fe3+ under acidic

conditions would encourage bacterial growth in these fluids, so the protein lactoferrin (Lf) is
used to bring iron to cells in contact with these fluids [4, 6, 9, 11, 13]. Lactoferrin does not release
Fe3+ under acidic conditions and therefore can traffic Fe3+ to epithelial tissues without making
the iron available to bacteria or fungi that may be present near these tissues [4, 9, 10, 12, 14].
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2.3.2 Infection Response Pathways
Should an infection establish itself in the body, the liver responds to inflammatory cytokines [9]
by producing the peptide hormone hepcidin [4, 6, 9, 10, 12]. Hepcidin suppresses the production of
ferroportin, a cation transport protein used to bring Fe3+ into the cytosol [4, 12]. Ferroportin
production is particularly suppressed in cells lining the GI tract, reducing iron absorption from
the diet [12].

Bacteria tend to acidify tissues they infect (mainly to generate the proton gradient necessary for
oxidative phosphorylation), so any Fe3+ in the area bound by transferrin (Tf) will be released to
solution and thus made available to the pathogens. Therefore, empty lactoferrin is trafficked to
the infected or inflamed site to scavenge any free Fe3+ in the area [4, 10-13].

2.4 Bacterial Response to Iron Sequestration
Bacteria have evolved many mechanisms to scavenge iron from their environment, whether that
environment is a human host or a matrix such as soil. These mechanisms include lysing
erythrocytes to internalize and degrade hemoglobin [6, 10, 13], internalizing and degrading Fetransferrin and Fe-lactoferrin [4, 10, 11, 13], lowering the pH of their environment to promote Fe3+
dissociation from Tf [10, 12], and siderophore production [4, 6, 9-11, 13]. This last pathway is
interesting from a chemical and molecular imaging perspective.

2.4.1 The Siderophore Pathway
Siderophores are small molecules synthesized and excreted by bacteria (and some fungi) to
harvest Fe3+ from their environment [4, 6, 9-11, 13] (figure 2-2). They bind Fe3+ with extremely high
affinity (binding constants on the order of ~1050 [14, 17]) but bind Fe2+ poorly, if at all.
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Figure 2-2: Representative siderophore structures: a) staphyloferrin A, b) pyochelin, c) DFO

After complexing Fe3+, the Fe-siderophore complex diffuses in the blood or interstitial fluid until
it encounters a bacterium expressing a particular surface receptor to which it can bind. After
binding to the surface receptor, the Fe3+ in the siderophore is internalized by a strain-specific
mechanism. Generalized schema for both Gram-positive and Gram-negative bacteria are shown
in figure 2-3, below.
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Figure 2-3: Siderophore uptake mechanisms in Gram-positive (left) and Gram-negative (right) bacteria [4]

In bacteria utilizing the siderophore pathway, the siderophores and receptors for the Fesiderophore complex are constitutively produced in small amounts [4, 6, 9-11, 13]. Lack of iron in
their environment de-represses the Fur operon, which is responsible for siderophore and receptor
production. The bacterium then produces and secretes relatively large quantities of its
siderophore(s) [4, 6, 9-11, 13].

2.4.2 Previous Medical Uses of Siderophores
Perhaps the most common use of siderophores is chelation therapy [4, 6, 12], in which
siderophores’ affinity for Fe3+ is exploited to remove Fe3+ from the blood. Patients with
excessively high blood Fe3+ concentrations are given the apo-siderophore desferrioxamine (DFO;
figure 2-4) intravenously. The apo-DFO complexes any free Fe3+ in the blood and is excreted
through the kidneys[18, 19] . Patients benefitting from chelation therapy include people with
hereditary iron-overload disorders (such as β-thalassemia) [4, 6] and transfusion dependent
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patients [20]. Patients given chelation therapy have been shown to have lower infection loads than
untreated patients, whose blood iron levels are higher [4, 6].

Figure 2-4: DFO-B, used in chelation therapy [17]

Siderophores have the potential to be molecular imaging agents. They bind specifically to their
target (particular species of bacteria), they are selectively taken up even at tracer concentrations
and they have the capacity to be modified to be tracked via non-invasive methods. These aspects
will be further explored in Chapter 3, in which the most effective way to convert siderophores
into molecular imaging tracers is examined.
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Chapter 3: Siderophores as Molecular
Imaging Agents
When constructing a molecular imaging tracer, it is important to ensure the imaging beacon and
targeting moiety are compatible. In the case of PET tracers, one must consider the decay
characteristics of the radionuclide, including half-life, β+ decay fraction, and the energy and type
of other decay modes. The chemical behavior of the radionuclide must be such that the tracer
atom may be easily and stably incorporated into the tracer without significantly altering the in
vivo behavior of the tracer [1]. In order to generate images of medical utility, the radionuclide
must remain with the tracer until the tracer reaches its target, preferably until the intact tracer is
cleared from the body [1].

3.1 Isotopes to Consider
Several radionuclides have characteristics that make them suitable candidates for radiolabeling
siderophores. They are all radiometals with chemistry similar to iron, enabling the siderophores
to be radiolabeled via a simple complexation reaction. Radiolabeling procedures of this type are
simpler, require less technical expertise to perform and reduce radiation dose to personnel
compared to the multi-step organic radiosynthetic techniques often used to incorporate
radioactive atoms into a molecule’s backbone, such as in the radiosynthesis of [18F]FDG [2].
Three radionuclides that could be fruitfully used to radiolabel siderophores are 52Fe, 68Ga and
89

Zr.

3.1.1

52

Fe

Because 52Fe (t1/2=8.3 h, avg Eβ+= 1.9 MeV [3]) is an isotope of iron, it should behave
approximately identically to the natFe3+ that siderophores chelate so selectively[1]. Therefore,
52

Fe-siderophore complexes will theoretically be taken up in exactly the same manner and at

essentially the same rate as the non-tracer natFe-siderophores. However, because many proteins
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in the human body also bind Fe3+ and several actually remove Fe3+ from Fe-siderophores (e.g.,
the lipocalins [4]), the presence of 52Fe at a site in the body might not necessarily indicate the
presence of 52Fe-siderophores at that site. The observed PET signal could be due to host proteins
sequestering 52Fe transchelated from the injected tracer and therefore be of little clinical use, as
the signal might not indicate localization of disease. Additionally, this nuclide is produced via
the 55Mn(p,4n)52Fe reaction [5, 6], which requires a large accelerator to accelerate protons to
sufficient energy (~50 MeV) [6]. There are many competing reaction channels and the cross
section for production of 52Fe is small. For all these reasons, the use of 52Fe has not been
pursued in this work.

3.1.2

68

Ga

Access to 68Ga (t1/2= 68 min, avg Eβ+=0.846 MeV [7]) is much simpler than 52Fe, since 68Ge/68Ga
generators are commercially available [8]. These generators typically consist of an ion exchange
column to which the parent nuclide (68Ge) is nearly permanently bound [1, 9-11]. When the parent
decays to the daughter, the daughter has a much lower affinity for the column material and can
be eluted with a suitable solvent. The eluted daughter can then be used for additional
radiochemical procedures.[1]. Generators are simple to operate, but they are relatively costly as
they must be wholly replaced when the parent material is depleted.

In addition to greater availability, 68Ga has the advantage of having chemistry similar to that of
Fe [12, 13]. Molecules that complex Fe3+ well (such as transferrin [8]) tend to complex Ga3+ readily,
so the siderophore imaging literature has focused on68Ga-labeled siderophores[14-17]. Ga has been
shown to have antimicrobial activity [12, 18, 19], so theoretically a 68Ga-siderophore tracer could be
used to localize an infection as well as show exactly where a natGa-siderophore (which would
specifically deliver cytotoxic doses of the metal to the infection site) would be taken up.
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3.1.3
89

89

Zr

Zr (t1/2=3.3 d, Avg Eβ+=0.9 MeV (22.7%) [20]) is an intriguing choice of radiometal for

transforming siderophores into PET tracers. While its chemistry is not as close to that of iron as
68

Ga, 89Zr does behave very similarly to iron [13] and therefore siderophores will likely complex

89

Zr readily. Its half-life is much longer than the biological half-lives of small molecules, but it

is likely to form very stable complexes, enabling the activity to be cleared from the body with the
tracer, thereby lowering radiation dose to the patient. It can be produced in high specific activity
on ordinary biomedical cyclotrons [21], allowing for wider use of the nuclide than 52Fe. However,
it emits an additional γ ray (0.91 MeV, 99%)[20] with each decay besides the 511 keV positron
peak, giving rise to dosimetry concerns for both patients and personnel.

89

Zr was chosen as an initial isotope for use in investigating siderophores as PET tracers, due to

its availability, ease of production and novelty as a signal for siderophore imaging.

3.1 Zirconium
3.2.1 Chemistry
Zirconium is a second row transition metal with a chemistry similar to that of iron. Its most
common oxidation state is Zr(IV) and it tends to form octavalent (or higher coordinate)
complexes [13]. Zr4+ is a very hard acidic cation [8] and thus strongly complexes with hard base
ligands, particularly those containing N- and O- donors [8, 13]. Many of these complexes, such as
Zr-desferrioxamine (Zr-DFO), are kinetically inert to demetallation [22].
The chemical literature for Zirconium focuses on the element’s coordination chemistry [23-25],
metallurgy (Zr is used as an alloying agent in steel, as well as cladding for fuel in nuclear
reactors) [1, 26-28], on zirconium-containing materials for medical devices [29-31], and on zirconium
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complexes as components of chromatographic resin for separations of metal ions [32, 33], peptides
[34]

, and small molecules [35].

3.2.2 Biological Role
While the metallurgical and strictly inorganic characteristics of Zr have been heavily investigated
(see above), its behavior in living systems has been poorly characterized. The element has no
known biological role [36, 37] and transport into any type of cell has never been shown. The
adsorption of free Zr to the surface of fungal spores [38], yeast spores [39] and Citrobacter [40] has
been demonstrated and characterized in bulk. This adsorption has been shown to depend on pH
[41, 42]

. However, there are no reports of transport of Zr into the cytosol of these potentially

infectious cell types. A search of several major databases (PubMed, Web of Science, Science
Direct) found only one publication discussing Zr uptake by any sort of infection [43].

3.2.2 Radiochemistry
Since 89Zr decays via positron emission, its location in a system may be ascertained by Positron
Emission Tomography (PET). Its fairly low-energy positrons (Eβ=0.9 (22.7%) and 2.4 (0.2%)
MeV [20]) allow high-resolution images to be obtained in vivo. However, reports of PET
imaging using 89Zr-based tracers have used very large molecular moieties, such as monoclonal
antibodies or other large proteins [44]. These tracers are imported into the cell to which they bind.
Because 89Zr is biologically inert, it must be attached to these tracers via a suitable bifunctional
chelator. The monoclonal antibodies used to target the HER2 receptor [44], Fibroblast activation
protein (overexpressed in Rheumatoid arthritis patients) [45], Prostate-specific antigen [32] and
other biological targets [44] do not chelate 89Zr4+ on their own. The chelator most commonly used
is 1-(4-Isothiocyanatophenyl)-3-[6,17-dihyroxy-7,10,18,21-tetraoxo-27- [Nacetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane]thiourea (DFO-NCS), an activated
derivative of desferrioxamine (DFO) [32]. DFO is a highly useful chelator: its Zr coordination
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chemistry is well-characterized, it completes quantitatively (when in present above tracer
concentrations) and the Zr complex is relatively stable in vivo [32]. If DFO is modified by the
addition of a benzyl isothiocyanate group, it can be easily conjugated to targeting moieties with
free amine groups, such as lysines [32].

3.3 Siderophore Library
The 89Zr complexation efficiency and bacterial uptake behavior of a library of synthetic
siderophores were examined. These siderophores were derived from danoxamine (fig. 3-1), a
natural product produced by Streptomyces violaceus (DSM 8286) [46, 47]. Danoxamine is the
iron-binding portion of the salmycin antibiotics these bacteria secrete [47]. While it does not
directly have anti-microbial activity, it ensures the specific uptake of salmycin antibiotics by
particular microbes.
Members of the library were previously synthesized by systematically modifying the
succinyl terminus of danoxamine with a variety of functional groups and variously-sized spacers
in order to probe the effect of pKa, stereochemistry, ligand identity and hydrogen bonding ability
on the ability of danoxamine to coordinate and complex metal ions [46].
The iron chemistry of the resulting library has already been thoroughly investigated [46, 48].
However, the zirconium chemistry of these compounds and uptake behavior as Zr complexes is
unknown.

3.4 Scope of this Work
This work investigates the possibility of using 89Zr-labeled siderophores as molecular imaging
agents for infection identification, as well as examining the conditions under which optimal
effective specific activity may be obtained for 64Cu.
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Because work with radiometals often requires extreme attention to the presence of contaminating
metal ions, Chapter 4 presents a thorough investigation of a complexation assay used to
determine the effective specific activity of 64Cu and proposes concrete suggestions for obtaining
precise, accurate and high ESA values when producing and using this radiometal. Chapter 5
explores the Zr chemistry of a library of danoxamine-derived siderophores and the specificity of
their uptake by a variety of bacterial species. Chapter 6 discusses the implications of these
results and explores future directions this research could take.
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Chapter 4: Sources of metal contamination
and specific activity measurement variations
in cyclotron produced 64Cu
NB: This work is currently out for review at Applied Radiation and Isotopes as “Sources of metal contamination and
specific activity measurement variations in cyclotron produced 64Cu” Nora C. Goscinski, Tara Mastren, Paul
Eisenbeis, Efrem Mebrahtu, Suzanne E. Lapi.

High effective specific activity (ESA) of 64Cu is important for high-efficiency radiolabeling with
this radiometal, but the sources of metal contaminants that can interfere with radiolabeling are
not fully known. Additionally, accurate determination of this parameter is important for
determining batch purity and the TETA titration, a common method for finding 64Cu ESA, has
not been fully characterized. The purpose of this study was twofold, firstly to identify sources of
metal contaminants in the 64Cu production process and secondly to identify metals that interfere
with the binding of 64Cu to the TETA chelator. Possible sources of contamination at all stages of
the 64Cu production process were identified. The Cu2+-TETA complexation reaction was
characterized for repeatability and interferences, and the interfering metal profiles of a variety of
reaction vessels and reagents were quantified. Our results indicate that the TETA titration
method for determining 64Cu ESA has both relative standard deviations of 27.6% and 40.3% for
repeatability and reproducibility respectively and the chelator TETA is selective for picomolar
amounts of Cu2+ in the presence of low millimolar concentrations of Zn2+ and Ni2+.
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4.1 Introduction
4.1.1

64

Cu Specific Activity and Sources of Contamination

The positron-emitting metal 64Cu is emerging as an important radionuclide for Positron Emission
Tomography (PET) and has been incorporated into radiopharmaceuticals for imaging a variety of
targets such as hypoxia [1-3], amyloid-β plaques [4,5] and numerous targets on cancer cells [6-9].
Producing this isotope in high specific activity is important for efficient radiolabeling and for the
production of high specific activity radiopharmaceuticals for imaging of low abundance targets.
Additionally, accurately determining the effective specific activity (ESA, radioactivity per µmol
of competing metal ions) of 64Cu is necessary as the presence of other metals in 64Cu may
decrease the radiochemical yield of a radiolabeling procedure. However, in selecting a method
for determining the ESA of a radiometal, it is important to consider the chemistry of the final
radiolabeling procedure. A quality control assay that is less selective than the chemistry to be
performed will give a falsely-low ESA value for the radiometal, while a QC procedure that is far
more selective could return a high ESA value that underestimates the effects of interfering
species in the final radiolabeling reaction.
Cold metal contaminants may enter cyclotron-produced 64Cu at many points during the
production process. Reagents used to prepare the 64Ni target may contain non-Ni metal atoms.
Trace amounts of dissolved metals in target cooling water could be deposited on the target
backing and inadvertently mixed with 64Cu during target processing. Additionally, the reagents
and resin used for post-bombardment processing may not be metal-free, and incomplete
separation of 64Cu and 64Ni may occur. Trace amounts of cold metals could leach from the
containers into which 64Cu is dispensed and stored. The reagents and vessels used for the TETA
titration itself may contain sufficient levels of extractable cold metals to interfere with
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complexation of Cu by the chelator. Finally, sample manipulation during target transfer,
dispensing and the TETA titration requires exposure to potential airborne metals.

4.1.2 ESA Determination
There are many methods of determining ESA of 64Cu, including ion chromatography [10], liquid
chromatography-mass spectrometry [11] and titration of Cu2+ with a selective chelator, most
typically 1,4,8,11-tetraazacyclotetradecane-1,4,8, 11-tetraacetic acid (TETA) [10, 12, 13]. TETA is
considered selective for Cu2+ because the binding constant (log K value) for Cu2+-TETA (log
K=21.7) [14,15] is larger than the log K values for Ni2+-TETA (19.9) [14,15], or Zn2+-TETA (log
K=16.4) [14,15]. (All log K values refer to the 𝑀 + 𝐿 ↔ 𝑀𝐿 equilibrium, where L is the
completely deprotonated chelator.) The TETA titration method is a popular method for
determining 64Cu ESA, but the assay itself has never been fully characterized as a method.
Additionally, while the effect of metal ions on the formation of other complexes, such as 68GaDOTA [16-18], 68Ga-NOTA [17-18] and 68Ga-DTPA [18] has been thoroughly examined, no such
analysis has been done for the formation of 64Cu-TETA in the presence of other metal ions.

4.1.3 Sources of Error
The goal of characterizing an assay is to determine the reliability of the results it returns. Some
of the aspects typically examined include the assay’s repeatability (precision when the same
sample is analyzed multiple times by a single analyst), reproducibility (precision when the same
sample is analyzed by different analysts), and robustness (precision and accuracy in the presence
of chemical contaminants or slight variations in experimental conditions), including the method’s
selectivity for the analyte in the presence of similar substances [19].
Potential sources of error in the TETA titration method of determining

64

Cu ESA include a

chelator that is either more or less selective than the chelator used in radiolabeling, a protocol
35

that is inherently low-throughput and vulnerable to human error, and the presence of other metals
in the reaction from a variety of sources.
All of the above sources of metal contamination and error in the 64Cu-TETA complexation
method were examined. The TETA titration was independently performed by two analysts for
17 batches of 64Cu. The extractable metal content for a variety of vessel types and reagents was
profiled and quantified. The effects of Ni2+ and Zn2+ on Cu2+-TETA complexation were
examined by spiking in the cold metals at a variety of concentrations and comparing the resulting
ESA to the ESA of pure (as received) 64Cu. Additionally, the repeatability and reproducibility of
the TETA titration results were examined and the metal content of the materials used in 64Cu
production and final 64Cu production batches were profiled and quantified by ion
chromatography.

4.2 Materials and Methods
4.2.1 Materials
All chemicals were trace-metal grade and used as received unless otherwise noted. In-house
milliQ water (18 MΩ-cm) was used to prepare solutions unless otherwise noted. 1,4,8,11tetraazacyclotetradecane-1,4,8, 11-tetraacetic acid (TETA) was purchased from Macrocyclics
(Dallas, TX).
Ammonium acetate, ammonium sulfate, methanol (reagent grade), TraceSelect Ultra water,
TraceCERT atomic absorption spectroscopy standards (1000 mg/L Fe3+, Cu2+, Ni2+, Zn2+ ,Co2+ in
nitric acid), and ethylenediaminetetraacetic acid (EDTA) were purchased from Sigma Aldrich
(St. Louis, MO). Glass-backed silica thin layer chromatography plates (silica gel 60 F-254) were
purchased from EMD Millipore (Billerica, MA). Nitric acid, 96-well plates (polystyrene),
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screwcap microcentrifuge tubes (virgin polypropylene, polypropylene screwcap with O-ring),
snaptop microcentrifuge tubes (high clarity polypropylene, DNase/RNase-free, pyrogen-free), 5
mL Polyvials for ASDV autosampler with plain caps, and 15 and 50 mL conical centrifuge tubes
(polypropylene, non-pyrogenic), were obtained from Fisher Scientific (Waltham, MA).
Polystyrene 96-well plates were also purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Ethanol (absolute) was purchased from DeCon Labs (King of Prussia, PA). Concentrated
PDCA eluent (35 mM pyridine-2,6-dicarboxylic acid, 330 mM KOH, 28 mM K2SO4, 370 mM
formic acid), solid 4-(2-pyridylazo)resorcinol (PAR), and PAR diluent (1.0 M 2dimethylaminoethanol, 0.50 M NH4OH, 0.30 M NaHCO3) were purchased from Dionex
(Sunnyvale, CA) and diluted to working concentrations with milliQ water and PAR diluent,
respectively. 5 mL (6 mL) Norm-Ject Luer-Lock syringes (polypropylene, pyrogen-free, sterile)
were purchased from Henke-Sass-Wolf (Tuttlingen, Germany) and used as received for manual
injections for ion chromatography. Target cooling water was sampled from the CS-15 cyclotron
and stored in polypropylene syringes before analysis.

64

Cu (as 64CuCl2) was produced in-house

using an automated module [21]. Concentrated sulfuric acid (99.9999% metals basis) and NH4OH
(99.99% metals basis) were purchased from Alfa Aesar (Ward Hill, MA).

4.2.2 Instrumentation
A high performance liquid chromatography unit consisting of a Dionex ICS-3000 HPLC with a 1
mL sample loop, a GP50 pump, an AD20 absorbance detector, an AS-DV autosampler and a
column heater (Thermo Scientific) was used for ion chromatography analysis. An IonPac CS5A
analytical column was used with an IonPac CG5A guard column (Dionex) to separate metals
extracted from vessels and reagents. The post-column reagent PAR (0.06 g/L) was delivered
using pressurized helium via a PC10 pneumatic controller (Dionex). For manual injections, the
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sample was injected onto the column using a 5 mL Norm-Ject syringe. When the AS-DV
autosampler was used to deliver sample to the column, EDTA- and acid-washed polyvials were
used. A CRC-25R dose calibrator (Capintec, Ramsey NJ) was used for all activity
measurements. TLC plates were analyzed for activity with a RadioTLC plate reader (Bioscan,
Washington DC).

4.2.3 Acid Washing
Strict acid-washing protocols were followed to ensure that reaction and storage vessels had
minimal extractable metal contents. Unless otherwise noted, vessels for use in the TETA
titration were acid washed as follows: complete immersion in 1:1 concentrated nitric acid: milliQ
H2O for ≥4 hours followed by a rinse with absolute ethanol. They were then dried overnight in
an oven (37⁰C). The acid-washed vessels were closed and stored in screw-top jars (subjected to
the same acid-washing protocol) until use. The polyvials used by the ASDV autosampler
required a more rigorous metal-extraction procedure before use: the vials and caps were rinsed
with milliQ H2O, soaked in 1 M EDTA (alkalinized with solid NaOH until all EDTA dissolved)
for at least 48 hours and again rinsed with milliQ H2O before immersion in a 1:1 HNO3:H2O
bath (described above) for a minimum of 48 hours. The autosampler vials and caps were stored
in the acid bath until use, when they were rinsed with milliQ H2O before being filled with
sample. In an attempt to reduce sample contamination, ion chromatography samples were
prepared immediately before analysis.

4.2.4 TETA Titration
The TETA titration was performed as previously described[12, 13]. Briefly, 7.4 MBq (200 µCi, 20
µL) 64Cu were added to a series of vials or wells in a 96-well plate containing 8 different
concentrations of TETA (in 0.1 M NH4OAc buffer, pH 5.5) and enough 0.1 M NH4OAc to bring
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the volume to 80 µL. The solutions were placed on a shaking incubator and incubated for 60
minutes at 80 ⁰C. The percent 64Cu complexation was determined via radioTLC: 1 µL aliquots
from each solution were spotted on TLC plates and developed in 1:1 MeOH: 10% NH4OAc (pH
5.5). Developed plates were placed on a RadioTLC plate reader for analysis. For interference
analysis, 40 µL Ni2+ or Zn2+ was added to the reaction before 64Cu; the volume of 0.1 M
NH4OAc was reduced accordingly.

4.2.5 Metal Profiles
Samples were prepared by heating 0.1 M NH4OAc at 80 ⁰C for 1 hour (as per the TETA titration
protocol) in a variety of reaction vessels. The heated NH4OAc was then diluted (1:200) with
milliQ water (for autosampler runs) or UltraTrace water (for manual injections). The samples
were separated and quantified as previously described [10]. Briefly, a 1 mL injection loop was
used to load samples onto the analytical column, PDCA eluent was pumped through the column
at 0.3 mL/minute and a post-column mixing loop was used to mix metals eluting from the
column with 4-(2-pyridylazo)resorcinol, which complexed metal ions in effluent. The
concentration of the metal-PAR complex was monitored via UV at 530 nm.

4.2.6 Analysis
Data were analyzed using Prism (Graphpad, CA). Selectivity coefficients were calculated using
an arbitrary low number of mols of Cu (1𝑥10−12 mols) for comparison, as the concentration of
Cu2+ ions in received 64Cu was typically below the detection limit of ion chromatography.

4.3 Results
4.3.1 Reproducibility and Repeatability
For the 17 64Cu production batches tested, the difference between ESA values obtained by
different analysts was significant (P=0.0196 for Analyst 1 vs Analyst 2). ESA values determined
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using TETA titration obtained by a single analyst for a single batch of 64Cu was variable and
ranged from 0.9 % to 27.6%. (Analyst 2 error bars, figure 4-1).
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Figure 4-1: Effective specific activity of 64Cu as determined by complexation with TETA. ESA’s before 7/17/13
were determined using acid-washed polypropylene vials. ESAs on or after 7/17/13 were determined using
polystyrene 96 well plates.

The ESA of 64Cu increases with batch size (R=0.390) and this effect is statistically significant.
However, batch size does not seem to affect the precision of the TETA assay, as the correlation
between batch size and the standard error of the mean is not statistically significant. The
variation in Cu-TETA complexation behavior (seen in the size of the standard error of the mean
ESA) is likely inherent to the complexation reaction itself, because more-precise ESA values are
not obtained for production batches with higher concentrations of 64Cu.

4.3.2 Selectivity of TETA for Cu2+
To verify the selectivity of TETA for Cu2+ in the presence of large excesses of other divalent
first-row transition metal ions, Zn2+ and Ni2+ were spiked into the TETA titration at a variety of
concentrations, the effect on 64Cu ESA was determined, and the selectivity coefficients of TETA
for Cu2+ in the presence of the contaminants were calculated. A value of Kanalyte interferent between
40

+1 and -1 indicates that the method is more selective for the analyte than the interferent [19].
When the interferences of Zn2+ and Ni2+ with Cu2+-TETA complexation were examined, KCu, Zn
was found to be 8.34𝑥10−4 while KCu. Ni was 4.62𝑥10−3 , indicating that while TETA is highly
selective for Cu2+, Ni2+ is more likely to interfere with Cu2+ complexation than Zn2+.
Ni2+ was spiked into the Cu-TETA complexation reaction to achieve final Ni2+ concentrations
ranging from 1.7 to 204 µM (figure 4-2; for clarity, only the lowest spike concentrations are
shown). As expected, the presence of Ni2+ lowered the ESA of 64Cu. When the difference in
ESA caused by the spike was normalized to the unspiked 64Cu ESA, the interference increased
linearly with Ni2+ concentration. At spike concentrations below 2.25 µM, ESA variation can no
longer be ascribed to the presence of spiked-in Ni2+, as the error bars for Ni2+-spiked and
unspiked 64Cu ESA’s overlap below this concentration.
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Figure 4-2: Effect of Ni2+ spike on 64Cu ESA
2+

Zn interference was determined by spiking Cu-TETA complexation reaction at a variety of
concentrations, from 2.75 to 183.5 µM (figure 4-3). The presence of Zn2+ lowered the ESA of
64

Cu at all but the lowest concentration tested (2.75 µM, figure 4-3). At spike concentrations

below 5.1 µM, the error bars for spiked and unspiked 64Cu-TETA complexation reactions
overlap; therefore, Zn2+ is no longer the sole cause of ESA variation below 5.1 µM.
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Figure 4-3: Effect of Zn2+ spike on 64Cu ESA

4.3.3 Sources of Interference: Metal content of vessels, reagents and 64Cu
Labeling buffer (0.1 M NH4OAc) was heated in a variety of reaction vessels made of different
types of plastic to determine extractable metal content. The vessels were incubated as received
and after acid-washing. The metal content of the labeling buffer after incubation was determined
via ion chromatography. Unheated labeling buffer and other reagents were also analyzed.
The labeling buffer was essentially metal free when prepared with milliQ water, with the
exception of Zn2+, which is present at levels below those found in all reaction vessels (table 4-1).
Polystyrene 96-well plates (as received) have the lowest extractable metal levels of all vessels
tested.
Acid-washing increased the Zn2+ content of molecular biology grade (DNase/RNase-free)
snaptop tubes nearly 9x, despite the use of trace metal grade HNO3. Trace metal grade HNO3
was found to contain approximately 7 µM Zn2+ (table 4-1), suggesting that direct transfer of Zn2+
from the acid bath to tubes is unlikely. It is possible the acid had time to loosen but not
completely liberate Zn2+ from the polypropylene matrix. However, acid washing appears to
lower the levels of extractable Cu2+ and Zn2+ in polypropylene screwtop tubes, suggesting that
different grades of polypropylene contain different concentrations of Zn2+.
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Table 4-1: Metal concentrations (µM) in TETA reaction mixture due to leaching from reaction vessel
Metal

Fe3+

0.1 M
NH4OAc
(pH 5.5)
< blank

Cu2+
Ni2+

< blank
< blank

Zn2+
Co2+

0.38
Not
detected
0.15

[TETA]
(well 5,
~EC50)
Plastic
Type

---

HNO3

96 well plate
(as received)

Screwtop vials
(as received)

<
blank
0.37
<
blank
7.20
<blank

< blank

< blank

Screwtop
Vials (acidwashed)
< blank

0.75
< blank

0.43
<blank

< blank
< blank

0.55
Not detected

68.35
<blank

11.37
< quant limit

0.15

0.15

0.15

0.15

--

Polystyrene

Polypropylene

Polypropylene

‘premium’ Snaptop
Vials* (as received)

‘premium’ Snaptop
Vials* (acid washed)

<blank
0.72

<quant limit
0.82

<blank
7.31

<quant limit
67.91

Not detected
0.15

<quant limit
0.15

High clarity
Polypropylene

High clarity
Polypropylene

*’Premium’ vials were molecular biology grade.

Quantification of the metal profiles of 64Cu production batches after decay found no significant
correlation between total metal content and ESA (figure 4-4). Additionally, cold metals were
found to be present at millimolar concentrations (table 4-2) while the TETA titration indicates
that Cu2+ is present at picomolar concentrations in CuOAc, so TETA is still highly selective for
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Figure 4-4: Effect of total metal content on precision of 64Cu ESA
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Table 4-2: Metal profiles of selected 64Cu production batches

Metal
(µM)
Fe3+
Cu2+
Ni2+
Zn2+
Co2+

6/18/2013

6/26/2013

7/9/2013

7/16/2013

7/23/2013

7/30/2013

1085

--

7/2/2013
--

--

--

--

--

--

--

--

--

16

--

--

2096

2794

2488

5486

1874

11416

5435

4023

8932

29214

--

5231

5583

33344

--

--

--

--

--

--

--

4.3.4 Sources of interference: Metal content of cyclotron target cooling
water and separation reagents
It has been noted [13] that target cooling water can be a source of cold metal contaminants in
cyclotron-produced 64Cu. Therefore, the metal content of cyclotron target cooling water was
examined via ion chromatography over several 64Cu productions. The total metal content of the
target cooling water tracks with 64Cu ESA—higher ESA is seen for batches with high metal
concentrations in the cooling water and a major drop in ESA is seen when metal content of
cooling water drops (due to water change-out; figure 4-5). However, the exact cause of this
relationship remains undetermined.
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Figure 4-5: Effect of CS-15 target cooling water metal content on 64Cu ESA

The resin and acid solutions used in target processing were also analyzed for metal content via
ion chromatography (table 4-3). When treated with 6 M HCl, unused AG1-X8 anion exchange
resin was found to have high levels of extractable Zn2+ (5604 μg/L) and Fe3+ (4136 μg/L), with
smaller amounts of Cu2+ and Ni2+. 0.5 M HCl, used to elute purified 64Cu during target
processing, had similarly high concentrations of Fe3+ and Zn2+. However, after passage through
a column of AG1-X8 resin, the 0.5 M HCl had no detectable Fe3+ and the Zn2+ content doubled
to 10,959 μg/L. The Ni content of the 0.5 M HCl increased from 744 μg/L to 1674 μg/L after
passing through the resin, while the Cu2+ content remained fairly constant (1546 μg/L pre-, 1414
μg/L post-column) This suggests that AG1-X8 resin binds Zn2+ at high concentrations of HCl,
but freely releases the metal when treated with 0.5 M HCl . Thus, the resin used to separate 64Cu
from the 64Ni target may be a major contributor to the cold metal contaminants found in
cyclotron-produced 64Cu.
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Table 4-3: Metal profiles of reagents used in 64Cu separation

Metal (μg/L)
Fe3+
Cu2+
Ni2+
Zn2+

0.5 M HCl
Pre-column Post-column
3930
-1546
1414
744
1674
5943
10959

6 M HCl passed
through fresh resin
4136
1546
589
5604

All the reagents used to prepare 64Ni targets contained Fe3+ (up to 2.87 mg/mL), while
(NH4)2SO4 also contained Ni2+ (1.59 mg/mL) and NH4OH contained Cu2+ (2.04 mg/L). Cobalt
was not detected in any target processing reagents.

4.4 Discussion
When comparing ESA values for a single batch of 64Cu obtained by different analysts, the
standard error of the mean ranged from 5.1% to 40.3% of the mean ESA, while the standard
error for ESA values obtained by a single analyst ranged from 0.9% to 27.6% of the mean. The
repeatability and reproducibility of the assay appear to be batch dependent. This may be due to
the extremely low analyte concentration, as typical concentrations of 64Cu are in the picomolar
range. At such low concentrations, it may take a long time for the chelator and metal ion to form
a complex and even tiny differences in reaction mixture composition or conditions can
dramatically affect the kinetics of the complexation process. Likely the thermodynamic product
(64Cu2+-TETA) is formed after a long incubation at high temperature, but perhaps 60 minutes at
80⁰C does not provide sufficient thermal energy to minimize the formation of kinetic products
such as Ni2+-TETA or Zn2+-TETA. Additionally, reaction pH may affect the affinity of a
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chelator for various metal ions. TETA was chosen for its high affinity for Cu2+ in its completely
deprotonated form, but at pH 5.5, other, more-protonated forms of TETA may exist, each with its
own set of stability constants.

There is a positive correlation between 64Cu batch size and ESA of the 64Cu (R= 0.390). A
possible explanation for the increase in specific activity with increasing amounts of 64Cu
produced is that the number of moles of cold interferents is essentially constant from batch to
batch, since they are inherent to the production process. Producing more activity would then
lead to higher ESA values, since the number of 64Cu atoms increases compared to the constant
number of interferent atoms.

The Cu2+-TETA complexation reaction is perturbed by high concentrations of other metals in the
reaction mixture. The mean ESA of 64Cu spiked with contaminant metals is lower (2.3-69.7%
lower) than the unspiked ESA for all production batches assayed. The macrocycle TETA does
complex Cu2+ with high selectivity, as indicated by complete complexation of 64Cu
(approximately picomolar) by only picomoles of TETA in the presence of micromoles of cold
Ni2+ and Zn2+, as well as by selectivity coefficient (for Cu2+) values much less than one.
However, the vast excess of cold Ni2+ and Zn2+ ions in the reaction vessel likely leads to their
complexation by TETA, giving rise to lower ESA values for 64Cu.

Cold Ni2+ and Zn2+ in the 64Cu come from a number of sources. Incomplete recovery of the 64Ni
target material is likely a source of cold Ni2+ which is present as the main contaminant. Cold
Zn2+ found in AG1-X8 resin itself may co-elute with 64Cu during target processing.
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Alternatively, the resin may concentrate cold Zn2+ from the target, plastics and solvents, then
release it in the same fraction as 64Cu. Additionally, many common plastic vessels contain
significant amounts of extractable, interfering metal ions even after acid-washing. Polystyrene
was found to have the lowest amount of extractable metals, though polypropylene could also be
nearly metal-free. The initial TETA titration assay was performed in virgin polypropylene vials
containing large quantities of extractable metals, and the ESA values obtained with these vials
are consistently lower than those obtained in other vessels. The use of polystyrene 96 well plates
to run the TETA complexation reaction gave consistently higher ESA values for 64Cu than
polypropylene vials and is inherently higher-throughput.

In order to obtain more accurate ESA values for batches of 64Cu, we recommend running the
TETA assay multiple times in parallel in polystyrene 96-well plates, using extremely high-purity
metal-free reagents. AG1-X8 resin used to separate 64Cu from 64Ni should be washed with 0.5 M
HCl before use to remove cold metal ions. If non-molecular-biology grade polypropylene is
used to run the TETA assay or to store 64Cu, the vessels should be thoroughly soaked in tracemetal grade acid to remove extractable metals from the plastic before use. Careful manipulation
of samples and vessels, with constant attention to the possibility of metal contamination, is also
necessary to obtain high ESA and realistic ESA values and for subsequent high specific activity
radiochemistry.

4.5 Conclusion
The Cu2+-TETA complexation assay has been characterized as a standard method. It is
perturbed by the presence of other first-row transition metal ions in the reaction mixture. Ni2+
interferes with Cu-TETA complexation at spike concentrations below 2.25 µM, while Zn2+
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interferes with the assay at spike concentrations below 5.1 µM. Sources of interfering metals
include Ni2+ and other metal ions from the target, ion exchange resin used in target processing,
and reaction vessel material with polystyrene and molecular biology grade polypropylene having
the smallest amounts of extractable metal ions.
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Chapter 5: 89Zr-siderophores as molecular
imaging agents for bacterial infections
Siderophores are small molecules synthesized by bacteria to harvest Fe3+ from their
environment. In infection scenarios, their production can increase infection virulence. Their
selective uptake in vivo in multi-bacteria environments indicates that this class of molecules has
the potential to be selective imaging agents. In this study, DFO-NCS and a library of
trihydroxamate siderophores were evaluated as vehicles to deliver 89Zr selectively to bacteria for
Positron Emission Tomography (PET) imaging of infections. The uptake of 89Zr-DFO-NCS by
human cells (SKBR3), Staphylococcus aureus, and Pseudomonas aeruginosa was significantly
different (p<0.0001) and highest for S. aureus. The Zr chemistry and bacterial uptake behavior
of a library of trihydroxamate siderophores was evaluated and compared to that of DFO-NCS.
Uptake of 89Zr-DFO-NCS and another siderophore library member (89Zr-V-129) were tested in a
murine lung infection model (P. aeruginosa, PA M57-15) and 89Zr-V-129 was found to have
significantly higher lung uptake in infected mice (p=0.0120) than in control mice. The uptake of
89

Zr-DFO-NCS did not differ significantly between control and infected mice (p=0.831).

89

Zr-

siderophores have the potential to be selective, specific PET tracers for imaging bacterial
infections in vivo and should be explored more thoroughly.

5.1 Introduction
Zirconium-89 is an emerging radiometal that has been successfully used to image a variety of
diseases in vivo. As discussed in section 3.2.1, 89Zr is biologically inert and must be attached to
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molecular imaging tracers via a suitable bifunctional chelator. The chelator most commonly
used is 1-(4-Isothiocyanatophenyl)-3-[6,17-dihyroxy-7,10,18,21-tetraoxo-27- [Nacetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane]thiourea (DFO-NCS), an activated
derivative of desferrioxamine (DFO) [1]. DFO is a highly useful chelator: its Zr coordination
chemistry is well-characterized ,the reaction completes quantitatively (when in excess) and the
Zr complex is relatively stable in vivo [1]. If DFO is modified by the addition of a benzyl
isothiocyanate group, it can be easily conjugated to targeting moieties with free amine groups,
such as lysines [1].

However, 89Zr-DFO alone has the potential to target certain diseases, such as bacterial infections,
as a small-molecule complex. One area of current interest in the infection imaging community is
the development of siderophore-based PET tracers.

Because siderophores chelate Fe3+ so avidly, they can be radiolabeled with radiometals whose
chemistry resembles that of Fe3+. In fact, DFO is a siderophore, originally produced by
Streptomyces pilosus [2, 3] and used clinically to lower the blood concentration of Fe3+ in patients
with hereditary iron-overload disorders (such as β-thalassemia) [4, 5] and transfusion dependent
patients [6] in addition to its use as a 89Zr chelator. While the literature has previously focused
on68Ga-labeled siderophores [7-10], 89Zr could also be used to transform a siderophore into an
infection-targeted PET tracer. While its chemistry is not as close to that of iron as 68Ga, 89Zr
does behave very similarly to iron [11] and therefore siderophores with similar structures to DFO
will likely complex 89Zr readily. These 89Zr-siderophore complexes are likely to be quite
kinetically stable, enabling the activity to be cleared from the body with the tracer, thereby
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lowering patient radiation dose.

89

Zr can be produced in high specific activity on a biomedical

cyclotron equipped with a solid target station [12], allowing for widespread use. Despite the many
advantages 89Zr has to offer the PET chemist, it has been neglected in the arena of infection
imaging. A search of several major databases (PubMed, Web of Science, Science Direct) found
only one publication discussing Zr uptake by any sort of infection [13].

We present herein the first report of using 89Zr to image bacterial infections.

89

Zr-DFO-NCS was

characterized as a tracer for bacterial infections. The 89Zr chemistry of a library of siderophores
based upon DFO was explored (see figure 5-1 for selected structures): the complexation
efficiency and stability towards demetallation of the 89Zr-siderophore complexes was examined
and the complexes’ uptake by a panel of Gram-positive and Gram-negative bacteria was
determined. Finally, the efficacy of 89Zr-siderophores as tracers for imaging bacterial infections
in vivo was tested by examining the uptake of 89Zr-DFO-NCS and the 89Zr complex of one
siderophore (V-129) by Pseudomonas aeruginosa (PA M57-15) in a murine lung infection
model.
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Figure 5-1: Selected chelators used in this study

5.2 Materials and Methods
5.2.1 Materials
All chemicals were reagent grade unless otherwise noted. In-house milliQ water (18 MΩ) was
used to prepare solutions unless otherwise noted. 1-(4-Isothiocyanatophenyl)-3-[6,17-dihyroxy7,10,18,21-tetraoxo-27-[N-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane]thiourea
(DFO-NCS) was purchased from Macrocyclics, Inc (Dallas, TX). HCl and NaOH were
purchased from Fisher Scientific (Waltham, MA). S. aureus (ATCC 11632) was provided by Dr.
Tim Wencewicz (Washington University, St. Louis), while Pseudomonas aeruginosa cultures
were provided by Dr. Steven Brody (Washington University, St. Louis). SKBR3 cells were
obtained from ATCC. An incubator, culture tubes, inoculation loops and petri dishes were
obtained from Fisher Scientific (Waltham, MA). Agar was purchased from Lambda Biotech
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(Ballwin, MO). LB (Miller) powdered media, diethylenetriaminepentaacetic acid (DTPA),
Deferoxamine mesylate (DFO), and 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid
(HEPES) were obtained from Sigma Aldrich (St. Louis, MO). Mannitol salt agar (MSA) was
obtained from VWR International (Radnor, PA). 70% ethanol was prepared using 200 proof
ethanol (in-house) and milliQ (18 MΩ-cm) H2O.

89

Zr was produced in-house using an

automated module [12] and was received as 89Zr-oxalate.

5.2.2
89

89

Zr Radiochemistry

Zr was neutralized in HEPES buffer (0.5 M, pH 7.1) and pH adjusted to 6.8-7.1 with NaOH

and/or HCl. Solid DFO-NCS was dissolved in DMSO (4-7 mg/mL) and diluted to 0.1 mg/mL in
HEPES. DFO-NCS and neutralized 89Zr were mixed to obtain an M:L ratio of 1:5, then
incubated on a shaker (Eppendorf thermomixer, Fisher Scientific) at 37 ⁰C for 60 minutes. The
extent of 89Zr chelation was determined by TLC. Briefly, 5 μL 50 mM DTPA (in milliQ H2O)
were added to an aliquot of the 89Zr-DFO-NCS complexation mixture and incubated at 37 ⁰C 5
minutes further before spotting on chromatography paper (CHR, Whatman, Pittsburgh, PA). The
strips were developed in 50 mM DTPA and analyzed for activity with a RadioTLC plate reader
(Bioscan, Washington DC). Likewise, siderophore library members were dissolved in water (1-2
mg/mL), then diluted in HEPES buffer (0.5 M, pH 7.1) to a working concentration of 0.1
mg/mL. The siderophore working solution and neutralized 89Zr were then mixed (M:L ~1:5) and
incubated on a shaker at 37 ⁰C. For bacterial uptake studies, the siderophores were allowed to
complex with 89Zr for 60 minutes. For stability studies, aliquots were removed at various times
and spotted on chromatography paper as above. The TLC strips were developed and visualized
as above.
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5.2.3 Biological Assays
Staphylococcus aureus and Pseudomonas aeruginosa were grown in a stationary incubator (37
⁰C) for 18-24 hours in LB (Miller) broth. 500 μL aliquots of the cultures were incubated at 37
⁰C with neutralized 89Zr or 89Zr-DFO-NCS (5 minutes, unless otherwise noted). The cells were
then centrifuged and washed twice with saline (0.9% NaCl) to remove non-specifically bound
89

Zr. Pellet activity was then quantified with a dose calibrator (CRC-25R, Capintec, Ramsey

NJ). The incubation time, cell concentration, 89Zr/89Zr-DFO-NCS dose and concentration of
Fe3+-depleting compounds in the media were all varied. Internalization was determined by
sonicating cell pellets (resuspended in sterile saline) for 5 minutes, followed by centrifugation.
The activity present in cytosol (supernatant) and membrane (pellet) fractions was then measured.

5.2.4 In vivo Studies
A clinical isolate of P. aeruginosa designated PA M57-15 (1X105 CFU/30ul) was intra-trachealy
instilled into mice (CD-1 white male, 6-8 weeks of age) one hour prior to imaging. 20 µg
siderophore (V-129 or DFO-NCS) were incubated with 1 mCi 89Zr in HEPES (0.5 M, pH 7.1) at
37°C for 1 hour, then diluted in saline. 70 – 90 µCi of the radiotracer was then injected into mice
intratracheally instilled either with PA M57-15 bacteria in PBS or PBS only (negative control).
Dynamic imaging was done for 0 – 40 min, followed by static imaging at 3 h post-injection. At
18 hours post-delivery of PA M57-15, the mice were euthanized for biodistribution studies.

5.3 Results and Discussion
5.3.1

89

Zr-DFO as baseline siderophore: in vitro studies

In order to determine whether chelation affects 89Zr uptake by bacterial cells, cultures of S.
aureus were treated with free 89Zr (neutralized, but not otherwise manipulated) and with 89ZrDFO-NCS (90-130 μCi/tube). After 5 minutes’ incubation at 37⁰, the cultures were centrifuged
and the activity present in each wash fraction, as well as the initial supernatant and final pellet,
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was quantified. The vast majority of 89Zr remained in the media in both cases, but when chelated
with DFO-NCS, up to 24.2% of 89Zr was found associated with S. aureus cells (figure 5-2a).
(Note that the percentages of free 89Zr do not add up to 100%. The difference was retained by
pipet tips.) Promisingly, unchelated 89Zr did not bind to or enter the bacterial cells at all.
Because ‘free’ 89Zr is not taken up by bacterial cells, any 89Zr uptake observed in vivo will be
from an intact 89Zr-siderophore, rather than a ‘lost’ ion of 89Zr.

Figure 5-2: a) Effect of chelation on binding of 89Zr to S. aureus cells; b) selectivity of 89Zr-DFO-NCS uptake by
mammalian cells, Gram-Positive bacteria (S. aureus) and Gram-negative bacteria (P. aeruginosa); and c) timedependence of 89Zr and 89Zr-DFO-NCS uptake by Gram-positive and Gram-negative bacteria

The selectivity of 89Zr-DFO-NCS uptake was investigated by incubating model Gram-positive
(S. aureus) and Gram-negative (P. aeruginosa) bacteria, as well as human cells (SKBR3), with
89

Zr-DFO-NCS as above. S. aureus bound the highest fraction of 89Zr-DFO-NCS (58.8 ±6.9%),

with P. aeruginosa binding significantly less (28.0±15.3%) and the mammalian cells binding
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nearly none (3.0±0.7%) of the applied complex (figure 5-2b). The extreme disparity between the
fraction of 89Zr-DFO-NCS bound by bacterial cells and mammalian cells indicates that the
complex may have the ability to selectively bind to/be taken up by bacterial cells in the presence
of mammalian cells, such as in the context of an infection. It also raises the possibility that 89ZrDFO-NCS may be a tracer well-suited to imaging bacterial infections in vivo, as there would be
very little off-target (non-infection) uptake. Additionally, the twofold higher uptake (p=0.0335)
of 89Zr-DFO-NCS by S. aureus than by P. aeruginosa indicates that the complex is selectively
taken up by Gram-positive bacteria. This selectivity suggests the possibility of developing moretargeted tracers (based on DFO-NCS) for identification of bacterial infections.

To examine the effect of incubation length on 89Zr-DFO-NCS uptake by the two types of
bacteria, cultures of both S. aureus and P. aeruginosa were treated with 5-10 μCi 89Zr
(neutralized oxalate complex) or 89Zr-DFO-NCS and incubated at 37⁰C (stationary) for
approximately 30 hours. While no uptake of free radiometal by either strain of bacteria was seen
at 60 minutes, by 28 hours post-labeling both S. aureus and P. aeruginosa showed slight uptake
of free 89Zr (S. aureus: 1.7±1.3%, P. aeruginosa 7.7±6.0%). As expected, uptake of 89Zr-DFONCS was much higher than that of the free radiometal at both 90 minutes and 29 hours (figure 52c). Interestingly, at 90 minutes, P. aeruginosa had much higher cell-associated activity
(16.1±14.4% vs 6.2±6.1% for S. aureus), whereas after 29 hours, S. aureus once more bound the
majority of the complex. Because very short (5-10 min) and very long (29 h) incubation periods
result in higher selectivity of 89Zr-DFO-NCS for S. aureus than intermediate time points, the
temporal aspect of bacterial uptake experiments with this complex should be carefully planned.
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When the uptake behaviors of unfunctionalized DFO and DFO-NCS were compared, only the
activated chelator was taken up (figure 5-3), while uptake of unfunctionalized DFO was
negligible. While this could indicate that DFO-NCS binds covalently to free amine groups on
cellular surfaces, the specificity of its uptake suggests that the story is more complex. When the
uptake of 64Cu-NOTA-NCS by the panel of bacteria was examined, all of the strains tested took
up a negligible amount of the NOTA-NCS complex. Because 64Cu-NOTA-NCS is essentially
not taken up while 89Zr-DFO-NCS is avidly taken up, the role of NCS in siderophore uptake is
likely more complex than simply serving to covalently anchor the siderophore complex to the
outer bacterial membrane.

Figure 5-3: Effect of p-Bn-SCN group on uptake of 89Zr-DFO by S. aureus, P aeruginosa and E coli.

5.3.2 Behavior of Siderophore Library
Of the siderophores examined, only 89Zr-III-116, 89Zr-IV-27, 89Zr-V-144, 89Zr-V-129 and 89ZrV-143 were taken up by any of the bacteria tested (figure 5-4a-b). While 89Zr-DFO-NCS was
taken up to varying extents by all bacteria tested (figure 5-4a), 89Zr-V-144 was only taken up by
Fe3+-deprived S. aureus (p<0.0001), indicating that 89Zr-V-144 may select for Gram-positive
organisms under infection-like conditions (figure 5-4b). Iron-starved E. coli took up over 10x
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more 89Zr-V-143 than Fe3+-deprived S. aureus (p=0.00057), indicating that 89Zr-V-143 may
select for Gram-negative organisms.

89

Zr-siderophore uptake is specific to bacterial type, growth

conditions and the siderophore itself, indicating that finding a siderophore avidly taken up by a
given bacterium may require testing a large library of compounds.

Figure 5-4: Uptake of 89Zr-siderophore complexes by Gram-positive and Gram-negative bacteria grown under a)
iron-replete conditions, b) iron-deficient conditions.

5.3.3 In vivo Studies
When 89Zr-DFO-NCS and 89Zr-V-129 were administered to mice with P. aeruginosa lung
infections, different clearance routes were observed for 89Zr-V-129 and 89Zr-DFO-NCS.

89

Zr-

DFO-NCS cleared through the kidneys as expected [14, 15] , while the 89Zr-V-129 complex
undergoing hepatobiliary clearance (figure 5-5c). When the lung uptake of infected and control
(uninfected) mice was examined, the uptake of 89Zr-V-129 was significantly higher (p=0.012) in
infected mice at early timepoints (12.5-32.5 minutes; figure 5-5a). For 89Zr-DFO-NCS, the
difference in lung uptake between infected and control mice was not significant (p=0.83; figure
5-5b). At the extended timepoint of the biodistribution study (>17 h post-injection), the lung
uptake of neither tracer was significantly different between infected and healthy mice (figure 560

5d). However, the difference in lung uptake seen 12.5-32.5 minutes post-injection for 89Zr-V129 is promising and shows that 89Zr-siderophores could be used as tracers for infection imaging.
Structural optimization is likely required to find a siderophore/bacteria combination with
enhanced uptake differences in vivo. Further studies are warranted to determine the optimal
siderophore structures for PET imaging of various types of infections.

Figure 5-5: : a) time-activity curve for 89Zr-V-129 in vivo; b) time-activity curve for 89Zr-DFO-NCS in vivo; c) in
vivo uptake of 89Zr-DFO-NCS and 89Zr-V-129 (static scan, 3 hr post-injection); d) biodistribution of 89Zr-DFO-NCS
and 89Zr-V-129 in mice (sacrificed 17 h post-injection)

5.4 Conclusion
The complex 89Zr-DFO-NCS has been validated as a radiotracer for bacteria. The complex is
selective for Gram-positive bacteria, but can be taken up slightly by the Gram-negative
Pseudomonas aeruginosa. Siderophores based on DFO are also selectively taken up by bacterial
cells in vitro and in vivo and therefore have the potential to be novel PET tracers when chelating
89

Zr.
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5.6 Supplementary Information

Figure 5-6: a) effect of varying cell (S. aureus and P. aeruginosa) concentration on uptake of 10 μCi 89Zr-DFO NCS; b) effect of varying 89Zr-DFO-NCS dose on tracer uptake by S. aureus and P. aeruginosa

Neat cultures of S. aureus and P. aeruginosa were spiked with 0 to 30 μCi 89Zr-DFO-NCS in
order to study the effect of dose on tracer fraction bound. The highest fraction of 89Zr-DFO-NCS
was found to stick when 5-10 μCi were administered to 500 μL culture. However, the total
amount of activity bound to each cell pellet was so small in this range that internalization studies
could not be performed with a dose calibrator. Consequently, 20 μCi/500 μL culture was
selected as the standard dose.
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Chapter 6: Concluding Remarks
Radionuclides have the potential to reveal reams of information about living systems,
information that cannot be easily obtained via other techniques. In particular, nuclei that emit
positrons can be incorporated into molecules in order to track the movement of the molecule
within a living system via PET imaging. Radiometals have the potential to probe systems which
move too slowly for the shorter-lived organic radioisotopes (18F, 11C) as well as systems in which
the movement of a particular metal is of interest. However, before a radiometal-radiotracer
combination can be fruitfully used to investigate biological questions, the radiochemistry of the
nuclide itself as well as the radiotracer as a whole must be thoroughly understood.

6.1 Efficacy of TETA Titration at Determining Effective
Specific Activity of 64Cu
The Cu2+-TETA complexation assay has been characterized as a standard method. It is
perturbed by the presence of other first-row transition metal ions in the reaction mixture. Ni2+
interferes with Cu-TETA complexation at spike concentrations below 2.25 µM, while Zn2+
interferes with the assay at spike concentrations below 5.1 µM. Sources of interfering metals
include Ni2+ and other metal ions from the target, ion exchange resin used in target processing,
and reaction vessel material with polystyrene and molecular biology grade polypropylene having
the smallest amounts of extractable metal ions.

Thoroughly understanding the intimate details of assays used to determine effective specific
activity of radiometals and other radionuclides is necessary for these materials to be used
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rationally. While the TETA titration assay is a useful tool for rapid determination of the quality
of a 64Cu batch, it is conducted on tracer-concentration material and therefore the presence of
contaminants several orders of concentration above the analyte will perturb the assay. However,
these contaminants will also affect the radiolabeling chemistry performed by the final user of the
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Cu. Therefore, care should be taken to eliminate or minimize the presence of contaminating

metal ions in production reagents and materials, storage vessels and containers for radiolabeling
when working with radiometals, particularly 64Cu.

6.2 Viability of 89Zr-siderophores as Tracers for PET
Imaging of Bacterial Infections
DFO-NCS, a well-established chelator for 89Zr, has been characterized as a targeting moiety in
itself when complexing 89Zr.

89

Zr-desferrixoamine and other 89Zr-radiolabled trihydroxamate

siderophore chelators have been shown to target bacterial cells in vitro. While their activity
towards bacteria when complexed with Fe3+ is well-characterized, these compounds retain their
affinity for bacteria when complexed with 89Zr4+. Compounds in a small library of siderophores
were examined for stability of 89Zr chelation and affinity for various Gram-positive and Gramnegative bacteria. Uptake specificity of these compounds varied: 89Zr-DFO-NCS was taken up
to varying extents by all bacteria tested, while some 89Zr-siderophore complexes were not taken
up by any of the strains, by only a fraction of the species or only when the bacteria were deprived
of Fe3+. The variations in uptake behavior indicate that 89Zr-siderophores have the potential to
be tracers that specifically identify living bacterial cells.

In vivo studies validated in vitro results. 89Zr-siderophores can be selectively taken up by
bacterial infection in vivo and tracer uptake is not seen in uninfected animals. While the results
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are not dramatic, tracer uptake in the area of infection (lung) was significantly higher in infected
than in control mice. However, this increased uptake was only true for one of the two tracers
tested, indicating that a given strain of bacteria will potentially only take up certain 89Zrsiderophores. Additional investigations in this area could lead to the identification of tracerbacterial pairs giving clinicians a powerful tool to confirm diagnoses, monitor infection
dynamics and determine appropriate courses of treatment for individual patients.

6.3 Future Directions
89

Zr-siderophores could be used in the future as radiotracers to image bacterial infections in vivo

via PET. However, these tracers must be thoroughly investigated in order to find the optimal
tracer to use for a given infection type before human imaging studies can begin. In the course of
this future investigation, methods will need to be validated, models confirmed and results
verified. The development of 89Zr-siderophores as PET tracers for bacterial infections promises
to be an interesting and fruitful endeavor with implications for personalized medicine.
For the correct tracer/ pathogen combination to be fruitfully used to investigate biological
questions, the radiochemistry of the nuclide itself as well as the radiotracer as a whole must be
thoroughly understood.
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